ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
LENSAR Inc

LENSAR Inc (LNSR)

10,6852
-0,1348
( -1,25% )
Aktualisiert: 15:59:14

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
10,6852
Gebot
10,57
Fragen
10,98
Volumen
15.205
10,4646 Tagesbereich 11,00
2,67 52-Wochen-Bereich 12,13
Marktkapitalisierung
Handelsende
10,82
Handelsbeginn
10,91
Letzte Trade
23
@
10.76
Letzter Handelszeitpunkt
16:00:29
Finanzvolumen
US$ 163.783
VWAP
10,7716
Durchschnittliches Volumen (3 Mio.)
67.457
Ausgegebene Aktien
11.614.807
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-8,74
Gewinn pro Aktie (EPS)
-1,24
Erlöse
42,16M
Nettogewinn
-14,38M

Über LENSAR Inc

LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual out... LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit. Mehr anzeigen

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
LENSAR Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker LNSR. The last closing price for LENSAR was US$10,82. Over the last year, LENSAR shares have traded in a share price range of US$ 2,67 to US$ 12,13.

LENSAR currently has 11.614.807 shares in issue. The market capitalisation of LENSAR is US$125,67 million. LENSAR has a price to earnings ratio (PE ratio) of -8.74.

LNSR Neueste Nachrichten

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors...

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., Jan. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors...

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., Dec. 09, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors...

LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day

ORLANDO, Fla., Nov. 26, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the...

LENSAR Reports Third Quarter 2024 Results and Provides Business Update

         24 ALLY Robotic Laser Cataract Systems™ placed in 3Q 2024 including 11 sales in EU and Southeast Asia; Robust backlog with 24 systems pending installation as of September 30, 2024 38...

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ORLANDO, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0648-0.60279069767410.7512.1310.3710584811.25357809CS
42.565231.59113300498.1212.137.2510099810.37703245CS
123.500248.71537926247.18512.137674579.15277607CS
265.7452116.2995951424.9412.133.5482597.58991645CS
526.3852148.4930232564.312.132.67407506.14605186CS
1564.825282.34129692835.8612.131.8264445.06468455CS
2607.5252238.1392405063.1612.711.8303156.38445183CS

LNSR - Frequently Asked Questions (FAQ)

What is the current LENSAR share price?
The current share price of LENSAR is US$ 10,6852
How many LENSAR shares are in issue?
LENSAR has 11.614.807 shares in issue
What is the market cap of LENSAR?
The market capitalisation of LENSAR is USD 125,67M
What is the 1 year trading range for LENSAR share price?
LENSAR has traded in the range of US$ 2,67 to US$ 12,13 during the past year
What is the PE ratio of LENSAR?
The price to earnings ratio of LENSAR is -8,74
What is the cash to sales ratio of LENSAR?
The cash to sales ratio of LENSAR is 2,98
What is the reporting currency for LENSAR?
LENSAR reports financial results in USD
What is the latest annual turnover for LENSAR?
The latest annual turnover of LENSAR is USD 42,16M
What is the latest annual profit for LENSAR?
The latest annual profit of LENSAR is USD -14,38M
What is the registered address of LENSAR?
The registered address for LENSAR is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the LENSAR website address?
The website address for LENSAR is www.lensar.com
Which industry sector does LENSAR operate in?
LENSAR operates in the SURGICAL,MED INSTR,APPARATUS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
GSIWGarden Stage Ltd
US$ 0,875001
(97,96%)
14,91M
MGOLMGO Global Inc
US$ 0,3431
(85,46%)
324,5M
CDTConduit Pharmaceuticals Inc
US$ 2,74
(76,77%)
44,89M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 16,40
(45,91%)
3,76M
CYTHCyclo Therapeutics Inc
US$ 1,115
(44,81%)
60,21M
NKLANikola Corporation
US$ 0,44
(-41,53%)
16,7M
RETOReTo Eco Solutions Inc
US$ 0,40
(-27,93%)
276,88k
CYNCYNGN Inc
US$ 0,0624
(-26,24%)
50,39M
NWLNewell Brands Inc
US$ 7,25
(-25,18%)
2,63M
SGBXSafe and Green Holdings Corporation
US$ 0,874109
(-24,65%)
1,76M
MGOLMGO Global Inc
US$ 0,3431
(85,46%)
292,04M
UPCUniverse Pharmaceuticals Inc
US$ 0,19
(18,01%)
112,66M
RIMEAlgorhythm Holdings Inc
US$ 0,0193
(-9,39%)
60,01M
CYTHCyclo Therapeutics Inc
US$ 1,115
(44,81%)
48,48M
NIVFNewGenIvf Group Ltd
US$ 0,15
(-3,29%)
46,13M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen